144 related articles for article (PubMed ID: 38555532)
1. A retrospective study on the effect of Chinese patent medicine combined with conventional treatment on the survival outcomes of 313 patients with stage II-III NSCLC.
Jia K; Zhang C; Li F; He B; Xie S; Du J; Feng G
Aging (Albany NY); 2024 Mar; 16(7):6212-6228. PubMed ID: 38555532
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study.
Wang L; Jia K; Li F; Zhang C; Feng G; Du J
Front Pharmacol; 2021; 12():719802. PubMed ID: 34539404
[No Abstract] [Full Text] [Related]
3. Conventional treatment integrated with Chinese herbal medicine improves the survival rate of patients with advanced non-small cell lung cancer.
Wang CY; Huang HS; Su YC; Tu CY; Hsia TC; Huang ST
Complement Ther Med; 2018 Oct; 40():29-36. PubMed ID: 30219465
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine].
Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST
Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic analysis of advanced non small cell lung cancer treated by sequential chemo-radiation therapy combined with traditional Chinese medicine: a report of 54 cases].
Han MQ; Su JM; Huang HY; Long WH; Qin LP; Qin P; Liu W; Sheng ZY
Zhong Xi Yi Jie He Xue Bao; 2003 Sep; 1(3):195-8. PubMed ID: 15339560
[TBL] [Abstract][Full Text] [Related]
6. Multidisciplinary and Comprehensive Chinese Medicine for Advanced Non-Small Cell Lung Cancer Patients: A Retrospective Study of 855 Cases.
Huang XG; Zhu LH; Zhou L; Xu WJ; Yao YL; Zhou ZY; Li HG
Chin J Integr Med; 2021 Jul; 27(7):490-495. PubMed ID: 32876856
[TBL] [Abstract][Full Text] [Related]
7. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
8. Prospective analysis on survival outcomes of nonsmall cell lung cancer stages over IIIb treated with HangAm-Dan.
Jeong TY; Park BK; Lee YW; Cho CK; Yoo HS
Zhongguo Fei Ai Za Zhi; 2010 Nov; 13(11):1009-15. PubMed ID: 21081039
[TBL] [Abstract][Full Text] [Related]
9. Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer.
Yan D; Wei P; An G; Chen W
J Cardiothorac Surg; 2013 Jun; 8():149. PubMed ID: 23759026
[TBL] [Abstract][Full Text] [Related]
10. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
[TBL] [Abstract][Full Text] [Related]
11. Integrated Chinese-western therapy versus western therapy alone on survival rate in patients with non-small-cell lung cancer at middle-late stage.
Lin G; Li Y; Chen S; Jiang H
J Tradit Chin Med; 2013 Aug; 33(4):433-8. PubMed ID: 24187861
[TBL] [Abstract][Full Text] [Related]
12. Survival is better predicted with a new classification of stage III unresectable non-small cell lung carcinoma treated by chemotherapy and radiotherapy.
Berghmans T; Lafitte JJ; Thiriaux J; VanHoutte P; Lecomte J; Efremidis A; Koumakis G; Giner V; Richez M; Corhay JL; Wackenier P; Lothaire P; Mommen P; Ninane V; Sculier JP;
Lung Cancer; 2004 Sep; 45(3):339-48. PubMed ID: 15301874
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.
Kim HC; Ji W; Lee JC; Kim HR; Song SY; Choi CM; ;
Cancer Res Treat; 2021 Oct; 53(4):1033-1041. PubMed ID: 33592139
[TBL] [Abstract][Full Text] [Related]
14. Effects of adjuvant chemotherapy on survival of patients with stage IB non-small cell lung cancer with visceral pleural invasion.
Xie J; Zhang X; Hu S; Peng WD; Xu B; Li Y; Zhang SJ; Li Q; Li C
J Cancer Res Clin Oncol; 2020 Sep; 146(9):2231-2239. PubMed ID: 32533405
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive treatment with Chinese medicine in patients with advanced non-small cell lung cancer: A multicenter, prospective, cohort study.
Liu J; Lin HS; Hou W; Hua BJ; Zhang PT; Li J; Wang SY; Xie Y; Zhang Y; Xie GR; Zhang MY; Shi WG; Guan NB; Guan TY; Li CH; Lu LY; Zhang Y; Li DR; Liu H
Chin J Integr Med; 2017 Oct; 23(10):733-739. PubMed ID: 27796823
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.
Xu ZY; Jin CJ; Zhou CC; Wang ZQ; Zhou WD; Deng HB; Zhang M; Su W; Cai XY
J Cancer Res Clin Oncol; 2011 Jul; 137(7):1117-22. PubMed ID: 21298288
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer.
Liao WY; Chen JH; Wu M; Shih JY; Chen KY; Ho CC; Yang JC; Yu CJ
Clin Lung Cancer; 2013 Jul; 14(4):418-24. PubMed ID: 23291258
[TBL] [Abstract][Full Text] [Related]
18. Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy.
Lee H; Jin GY; Han YM; Chung GH; Lee YC; Kwon KS; Lynch D
Cardiovasc Intervent Radiol; 2012 Apr; 35(2):343-50. PubMed ID: 21626257
[TBL] [Abstract][Full Text] [Related]
19. Impact of Staging With Positron-emission Tomography (PET) and Comorbidities on Management and Survival of American Veterans With Stage I-III Non-Small Cell Lung Cancer.
Raghunathan R; Cease K; Troeschel S; Zhao L; Gross M; Chen G; Chopra V; Ramnath N
Am J Clin Oncol; 2018 May; 41(5):513-518. PubMed ID: 27322696
[TBL] [Abstract][Full Text] [Related]
20. Sex is a strong prognostic factor in stage IV non-small-cell lung cancer patients and should be considered in survival rate estimation.
Barquín M; Calvo V; García-García F; Nuñez B; Sánchez-Herrero E; Serna-Blasco R; Auglytė M; Carcereny E; Rodriguez-Abreu D; López Castro R; Guirado M; Camps C; Bosch-Barrera J; Massuti B; Ortega AL; Del Barco E; Gonzalez-Larriba JL; Aguiar D; García-Campelo R; Dómine M; Agraso S; Sala MA; Oramas J; Bernabé R; Blanco R; Parejo C; Cruz A; Menasalvas E; Royuela A; Romero A; Provencio M
Cancer Epidemiol; 2020 Aug; 67():101737. PubMed ID: 32450544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
